State Of The Science At FDA: Catching Up With Jesse Goodman
This article was originally published in The Gray Sheet
Executive Summary
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original raison d'etre: improving the agency's scientific capacity and integrity
You may also be interested in...
FDA Eyes The Future: 2010 Workshop To Address Integration Of "New Science"
FDA's device center will hold a public workshop in February to help formulate a strategy for integrating "new science" into its regulatory decisions
FDA Reorganization Elevates Scientific And Food Safety Priorities
FDA moved four offices to the deputy commissioner level in a reorganization of the Office of the Commissioner formalized Aug. 18
First Showing Of New FDA Leadership Comes In Public Health Emergency
With the swine flu outbreak, FDA's new leadership is getting its first real exposure right in the middle of an international public health crisis